246 related articles for article (PubMed ID: 18480440)
1. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
Komala Sari T; Gianopulos KA; Nicola AV
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
[TBL] [Abstract][Full Text] [Related]
3. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.
Lubinski JM; Jiang M; Hook L; Chang Y; Sarver C; Mastellos D; Lambris JD; Cohen GH; Eisenberg RJ; Friedman HM
J Virol; 2002 Sep; 76(18):9232-41. PubMed ID: 12186907
[TBL] [Abstract][Full Text] [Related]
5. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
Cairns TM; Huang ZY; Whitbeck JC; Ponce de Leon M; Lou H; Wald A; Krummenacher C; Eisenberg RJ; Cohen GH
J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
[TBL] [Abstract][Full Text] [Related]
6. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors.
Atanasiu D; Cairns TM; Whitbeck JC; Saw WT; Rao S; Eisenberg RJ; Cohen GH
mBio; 2013 Feb; 4(2):. PubMed ID: 23443004
[TBL] [Abstract][Full Text] [Related]
7. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.
Awasthi S; Lubinski JM; Friedman HM
Vaccine; 2009 Nov; 27(49):6845-53. PubMed ID: 19761834
[TBL] [Abstract][Full Text] [Related]
8. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
[TBL] [Abstract][Full Text] [Related]
9. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
Ghiasi H; Kaiwar R; Nesburn AB; Slanina S; Wechsler SL
J Virol; 1994 Apr; 68(4):2118-26. PubMed ID: 8138996
[TBL] [Abstract][Full Text] [Related]
10. Multiple Sites on Glycoprotein H (gH) Functionally Interact with the gB Fusion Protein to Promote Fusion during Herpes Simplex Virus (HSV) Entry.
Fan Q; Hippler DP; Yang Y; Longnecker R; Connolly SA
mBio; 2023 Feb; 14(1):e0336822. PubMed ID: 36629412
[TBL] [Abstract][Full Text] [Related]
11. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
12. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
[TBL] [Abstract][Full Text] [Related]
15. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
[TBL] [Abstract][Full Text] [Related]
16. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.
Nagashunmugam T; Lubinski J; Wang L; Goldstein LT; Weeks BS; Sundaresan P; Kang EH; Dubin G; Friedman HM
J Virol; 1998 Jul; 72(7):5351-9. PubMed ID: 9620988
[TBL] [Abstract][Full Text] [Related]
17. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
Friedman HM; Wang L; Fishman NO; Lambris JD; Eisenberg RJ; Cohen GH; Lubinski J
J Virol; 1996 Jul; 70(7):4253-60. PubMed ID: 8676446
[TBL] [Abstract][Full Text] [Related]
18. Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes.
Hilterbrand AT; Daly RE; Heldwein EE
mBio; 2021 Mar; 12(2):. PubMed ID: 33653890
[TBL] [Abstract][Full Text] [Related]
19. Oligomeric structure of glycoproteins in herpes simplex virus type 1.
Handler CG; Eisenberg RJ; Cohen GH
J Virol; 1996 Sep; 70(9):6067-70. PubMed ID: 8709230
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry.
Handler CG; Cohen GH; Eisenberg RJ
J Virol; 1996 Sep; 70(9):6076-82. PubMed ID: 8709231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]